# Malignant Pleural Effusion With ZD6474

> **NCT00402896** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 28 (actual)

## Conditions studied

- Lung Cancer
- Pleural Effusion

## Interventions

- **DRUG:** ZD6474

## Key facts

- **NCT ID:** NCT00402896
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2016-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402896, "Malignant Pleural Effusion With ZD6474". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00402896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*